Equities

SNDL Inc

SNDL Inc

Actions
  • Price (USD)2.22
  • Today's Change-0.25 / -10.12%
  • Shares traded14.54m
  • 1 Year change+44.16%
  • Beta3.2731
Data delayed at least 15 minutes, as of May 01 2024 21:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SNDL Inc. is a Canada-based private-sector liquor and cannabis retailer in Canada with retail banners, which include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, and Firesale Cannabis. Its segments include Liquor Retail, Cannabis Retail, Cannabis Operations and Investments. The Liquor Retail segment includes the sale of wines, beers and spirits through liquor stores. The Cannabis Retail segment includes the private sale of recreational cannabis through and franchise retail cannabis stores. The Cannabis Operations segment includes the cultivation, distribution and sale of cannabis for the adult-use and medical markets domestically and for export, and providing cannabis processing services, in addition to product development, manufacturing, and commercialization of cannabis consumer packaged goods. The Investments segment includes the deployment of capital to investment opportunities. Its cannabis brand portfolio includes Top Leaf, Vacay, Grasslands and others.

  • Revenue in USD (TTM)659.80m
  • Net income in USD-122.03m
  • Incorporated2006
  • Employees2.52k
  • Location
    SNDL Inc919 11 AVENUE SW, SUITE 300Calgary T2R1P3CanadaCAN
  • Phone+1 (403) 948-5227
  • Fax+1 (403) 948-5227
  • Websitehttps://www.sndl.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wave Life Sciences Ltd113.31m-57.51m602.86m266.00--14.82--5.32-0.5397-0.53971.070.39870.5378----425,958.70-27.30-56.98-70.41-102.38-----50.76-353.20----0.00--3,005.1051.0464.46---35.44--
Zymeworks Inc76.01m-118.67m605.48m272.00--1.31--7.97-1.74-1.741.106.570.1236--2.88279,455.90-19.30-22.58-22.01-26.90-----156.13-91.17----0.0003---81.577.47-195.44--3.58--
Novavax Inc983.71m-545.06m606.00m1.54k------0.616-5.53-5.539.42-5.140.4858.765.18637,527.60-26.88-46.06---269.5765.10---55.41-75.940.6741-38.31-----50.3695.6817.16--108.28--
Mineralys Therapeutics Inc0.00-71.90m607.98m28.00--2.09-----1.79-1.790.005.860.00----0.00-39.28---41.38--------------0.00-------141.28------
Cogent Biosciences Inc0.00-192.41m621.49m164.00--2.83-----2.40-2.400.002.990.00----0.00-62.65-49.53-70.07-54.94-------1,684.44----0.00-------37.20--38.48--
SIGA Technologies Inc139.92m68.07m624.18m45.009.343.179.094.460.93990.93991.952.770.62270.33294.213,109,272.0030.2922.3436.4227.5687.6988.6548.6541.143.23--0.0029.5126.31-21.75100.76-30.57-26.67--
Exscientia PLC (ADR)25.08m-182.31m624.29m483.00--1.40--24.89-1.45-1.450.19953.530.03461,096.089.8651,922.75-25.16---29.09---36.47---726.94--6.22--0.0505---26.24---22.94------
Dianthus Therapeutics Inc2.83m-43.56m626.59m53.00--1.87--221.72-10.77-10.770.442911.400.0173----53,320.75-26.72-41.40-28.86-44.70-----1,541.22-12,132.27----0.00------43.04---57.21--
Savara Inc0.00-54.70m632.85m37.00--4.51-----0.3424-0.34240.001.020.00----0.00-34.47-36.86-36.36-39.54-------102,587.50----0.158-------43.38--15.91--
Sinovac Biotech Ltd420.88m-359.71m639.90m3.56k------1.52-3.63-3.633.9487.080.02922.750.6035118,289.80-5.0955.60-7.7793.17-46.9691.39-174.0067.889.74--0.0174---92.3053.64-98.7333.12102.27--
SNDL Inc659.80m-122.03m643.41m2.52k--0.7378--0.9752-0.4685-0.48112.553.350.59955.2936.58262,241.50-11.34-24.44-12.28-27.9424.1722.49-18.92-62.172.69-9.290.1196--27.63--49.83------
Kyverna Therapeutics Inc0.00-60.37m652.76m96.00---------1.39-1.390.001.14------0.00--------------------0.0368---100.00---108.93------
Hillevax Inc0.00-123.57m656.05m90.00--2.37-----3.04-3.040.005.570.00----0.00-37.35---39.90--------------0.0868------22.68------
AnaptysBio Inc17.16m-163.62m664.94m117.00--7.35--38.76-6.07-6.070.63723.310.0323--4.15146,641.00-30.79-18.08-32.75-18.96-----953.66-269.21----0.00--66.7827.97-27.11---5.36--
Y-mAbs Therapeutics Inc84.82m-21.43m665.85m100.00--6.58--7.85-0.4909-0.49091.942.310.62991.934.85848,190.00-15.91-44.23-19.40-50.4586.60---25.26-181.135.27--0.00--29.96--77.58------
Phibro Animal Health Corp982.01m14.80m676.41m1.92k45.712.5013.630.68880.36540.365424.246.691.022.376.49511,465.601.535.461.876.8330.4331.411.515.111.602.500.636942.993.783.59-33.69-13.5622.803.71
Data as of May 01 2024. Currency figures normalised to SNDL Inc's reporting currency: US Dollar USD

Institutional shareholders

4.09%Per cent of shares held by top holders
HolderShares% Held
Global X Management Co. LLCas of 31 Dec 20232.96m1.13%
Horizons ETFs Management (Canada), Inc.as of 31 Dec 20232.07m0.79%
Citadel Securities LLCas of 31 Dec 20231.49m0.57%
Morgan Stanley & Co. LLCas of 31 Dec 20231.12m0.43%
AdvisorShares Investments LLCas of 31 Dec 2023809.21k0.31%
Susquehanna Financial Group LLLPas of 31 Dec 2023554.09k0.21%
Group One Trading LPas of 31 Dec 2023540.56k0.21%
Invesco Capital Management LLCas of 31 Dec 2023503.07k0.19%
SSgA Funds Management, Inc.as of 31 Dec 2023352.01k0.13%
Dimensional Fund Advisors LPas of 31 Dec 2023351.09k0.13%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.